"This is a data-driven industry. One of the things I love about it is that people can doubt you one day and be your biggest cheerleaders the next because you've shown them data that change their paradigm."
– Tim Mayleben, president and CEO, Aastrom Biosciences Inc.

"Since the placebo rate is 30 percent, we figure in our trial we can help everybody."
– Overheard at the BioPartnering North America conference

"You have to manage it. Like anything else."
– Brian Dovey, partner with Domain Associates, on the risks of conducting clinical trials in Russia

"We have to figure out how to be more capital efficient. We can't continue to fund companies only to have them be marked down."
– Bijan Salehizadeh, co-founder and managing director of NaviMed Capital, on the troubles of the biotech venture industry